PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

WORLD FIRST: REVOLUTIONARY PROCEDURE FOR TYPE 2 DIABETES LAUNCHES IN LONDON

Revita is a non-drug, minimally-invasive therapeutic procedure for type 2 diabetes that improves blood sugar controlThe one-hour, same-day treatment targets the duod...
Continue Reading →
News

HIV transmissions fall by 71%

A new report has revealed that among gay, bisexual and other men who have sex with men, the prevalence of HIV transmission has fallen by a staggering 71%. The numb...
Continue Reading →
News

‘Weak antibiotic pipeline’ poses threat to AMR fight

The World Health Organisation (WHO) has revealed that declining private investment and lack of innovation in the development of new antibiotics are undermining effor...
Continue Reading →
News

New scan could see active breast tumour regions in ‘real-time’

Cancer Research UK has announced that a new type of scan involving magnetising molecules could allow doctors to see in real-time which regions of a breast tumour are...
Continue Reading →
News

EU clears Roche’s Polivy for certain lymphomas

The European Commission has approved Roche’s Polivy (polatuzumab vedotin) for people with previously treated aggressive lymphoma. The Commission’s marketing author...
Continue Reading →
News

Fight for Sight to fund macular degeneration research

Fight for Sight, a UK-based eyesight research charity, has announced that it will funding researchers from the University of Manchester to investigate the genet...
Continue Reading →
News

Novartis, NHS strike ‘innovative’ cardiovascular deal

Novartis has announced plans to partner with the NHS in a “world-first” approach to addressing cardiovascular disease (CVD). The collaboration, which could see the...
Continue Reading →
News

Genomics England, Illumina join forces on whole genome sequencing

Genomics England and Illumina have jointly announced a new agreement, which will see them deliver up to 300,000 whole genome equivalents over the next five years, wi...
Continue Reading →
News

Horizon enlists Mammoth in CRISPR move

Horizon Discovery has announced a new collaboration and license agreement with Mammoth Biosciences, in order to access the company’s novel CRISPR platform and facili...
Continue Reading →
News

Elasmogen secures £2m to support next gen biologics

Aberdeen University spin-out Elasmogen has announced the securing of follow-on equity investment from Deepbridge Capital totalling £2 million, taking the company’s t...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026